Table 3 Assessment of Prescription Quality According to Drug
From: Antifungal stewardship in a tertiary care paediatric hospital: the PROAFUNGI study
Drug | Patients, n | Prescriptions Evaluated, n | Non-optimal Prescriptions (n, %) | Cause a |
|---|---|---|---|---|
Liposomal amphotericin B | 27 | 105 | 12 (11%) | - Unnecessary (9) |
- Inappropriate (2) | ||||
- Inadequate: incorrect dose (5), incorrect duration (7), disagreement with institutional protocol b (5) | ||||
Posaconazole | 12 | 32 | 1 (3%) | - Inadequate, incorrect dose (1) |
Anidulafungin | 11 | 29 | 3 (10%) | - Unnecessary (3) |
Fluconazole | 11 | 25 | 1 (4%) | - Inadequate, incorrect dose (1) |
Isavuconazole | 2 | 9 | 5 (56%) | - Inadequate: disagreement with institutional protocol** (5) |
Micafungin | 3 | 7 | 2 (29%) | - Unnecessary (2) |
- Inadequate: disagreement with institutional protocol b (2) | ||||
Voriconazole | 2 | 5 | 0 | N/A |
Caspofungin | 1 | 4 | 0 | N/A |
Itraconazole | 2 | 3 | 0 | N/A |